​Due to the rarity of malignancies arising from the small bowel, there are no recommended surveillance guidelines.

Patients with a small bowel adenocarcinoma are known to have a higher incidence of secondary malignancies involving the colon, rectum, ampulla of Vater, endometrium and ovary which warrants early investigation of any worrisome symptoms.